cancer-specific survival 肿瘤特异生存率 例句筛选 1.Overall, cancer specific survival at 5-years for this cohort was 48%.总计，此病例研究组的5年癌症特异生存率为48%。2.The important prognostic factors for cancer specific survival were the priorrecurrence history and histological grades.影...
cancer-specific survival 肿瘤特异性生存拼音双语对照双语例句 1 PSADT is an important prognostic factor that may serve as an auxiliary end point for cancer-specific survival; PSADT作薯如凳为一橡乱个重要的预后因子,可能在癌症特异性存活中作为数旅一个辅助性终点指标; 03分享举报您可能感兴趣的内容广告 su...
cancer specific survival 肿瘤特异性生存 如果你对这个答案有什么疑问，请追问，另外如果你觉得我的回答对你有所帮助，请千万别忘记采纳哟！
partialnephrectomy, women had significantly better disease-specific (HR 0.75) and overall (HR 0.80) survival rates than their male counterparts.51In a SEER-based study, Aaron et al. also reported a better overall survival in women compared to men; cancer-specific survival did, however, not ...
Sickle cell disease (SCD) patients have a higher incidence of certain cancers, but no studies have determined the impact of cancer on survival among SCD patients. SCD patients (n = 6423), identified from state﹚ide hospitalisation data, were linked to the California Cancer Registry (1988–2014...
cancer-specific survival 肿瘤特异性生存拼音双语对照双语例句 1 PSADT is an important prognostic factor that may serve as an auxiliary end point for cancer-specific survival; PSADT作为一个重要的预后因子，可能在癌症特异性存活中作为一个辅助性终点指标；
Background Two main methods of quantifying cancer patient survival are generally used: cancer-specific survival and relative survival. Both techniques are used to estimate survival in a single population, or to estimate differences in survival between populations. Arguments have been made that the relat...
Kaplan–Meier analysis was used to assess the prognostic effect of TBR on cancer-specific survival (CSS), and univariate log-rank test and multivariate Cox proportional hazards regression model were performed to identify independent prognostic factors. The optimal cutoff value of TBR was determined to...
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review[J] . Sven van den Bosch,J. Alfred Witjes.European Urology . 2011 (3)van den Bosch S, Witjes JA. Long-term cancer-specific survival in patients with...
The prognostic factors for survival among patients with secondary osteosarcoma remain unclear. The aim of this study was to develop a practical nomogram for predicting cancer-specific survival (CSS) in patients with osteosarcoma as a secondary malignancy